Telomir Pharmaceuticals Files 8-K
Ticker: TELO · Form: 8-K · Filed: May 7, 2025 · CIK: 1971532
Sentiment: neutral
Topics: 8-k, other-events
TL;DR
Telomir Pharma filed an 8-K, but details are scarce. Watch for updates.
AI Summary
Telomir Pharmaceuticals, Inc. filed an 8-K on May 7, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.
Why It Matters
This 8-K filing indicates a material event has occurred for Telomir Pharmaceuticals, Inc., but the lack of specific details requires further investigation to understand the implications.
Risk Assessment
Risk Level: medium — The filing is an 8-K, indicating a significant event, but the lack of specific information within the provided text introduces uncertainty.
Key Players & Entities
- Telomir Pharmaceuticals, Inc. (company) — Registrant
- May 7, 2025 (date) — Filing Date
- Florida (location) — State of Incorporation
- Miami (location) — Principal Executive Offices City
FAQ
What specific event(s) are being reported under "Other Events" in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the "Other Events."
When was the earliest event reported in this filing?
The earliest event reported is May 7, 2025, which is also the date of the report.
What is the principal business address of Telomir Pharmaceuticals, Inc.?
The principal executive offices are located at 100 SE 2nd St, Suite 2000, #1009, Miami, Florida.
What is the IRS Employer Identification Number (EIN) for Telomir Pharmaceuticals, Inc.?
The IRS Employer Identification Number is 87-2606031.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K being filed?
This Form 8-K is being filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Telomir Pharmaceuticals, Inc. (TELO).